Musaffa Logo

Our certifications

Independent proof that every stock and portfolio meets halal standards.

How we screen every stock
METHODOLOGY

How we screen every stock

Our 5-step halal methodology, in 90 seconds.

CCEL Shariah Compliance

Screening Methodology: AAOIFI

HALAL

Last Updated: June 14, 2026

Report Source: 2026 1st Quarter Report

Analyst's Ratings for Cryo-Cell International Inc (CCEL)

Based on 6 analysts giving stock ratings to Cryo-Cell International Inc in the past 3 months

Strong
Sell
SellHoldBuyStrong
Buy
Strong Buy
0
Buy
0
Hold
50
Sell
17
Strong Sell
33
Cryo-Cell International Inc

Cryo-Cell International Inc. Stock Analysis CCEL

United States Health Care Nano Cap Report:
Cryo-Cell International, Inc. is a cord blood bank, which engages in providing stem cell cryopreservation services and advancing regenerative medicine. The company is headquartered in Oldsmar, Florida and currently employs 72 full-time employees. The firm operates through three segments: cellular processing and cryogenic storage for family use, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells; manufacture of PrepaCyte CB Processing System (PrepaCyte CB) units, the processing technology used to process umbilical cord blood stem cells, and cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The firm stores approximately 240,000 cord blood and cord tissue specimens. The specimens are stored in commercially available cryogenic storage units at its technologically and operationally advanced facility. The firm markets its cord blood stem cell preservation services directly to expectant parents and by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals.
Read More

Cryo-Cell International Inc (CCEL) Chart

Key Statistics of Cryo-Cell International Inc (CCEL)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$3.45$3.50

Today's Open

$3.45

Volume

1811.00

P/E Ratio (TTM)

-

52 Week Range

$2.72$6.35

Market Cap

27.71M

Avg. Volume

6347.95

Dividend Yield

14.32%

Financial Metrics & Statements of Cryo-Cell International Inc (CCEL)

FAQ's for Cryo-Cell International Inc (CCEL)

  • According to Musaffa’s Shariah screening methodology, Cryo-Cell International Inc (CCEL) is currently classified as HALAL as of June 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.
  • A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Cryo-Cell International Inc using these criteria to determine its compliance status.
  • Muslim investors may consider investing in Cryo-Cell International Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
  • Musaffa determines the Shariah status of Cryo-Cell International Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
  • The Shariah compliance status of Cryo-Cell International Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
  • Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
  • You can check the latest Shariah compliance status of Cryo-Cell International Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Disclaimer

The content provided on this website is intended solely for informational and educational purposes. Musaffa is a technology, data, education, and research company. We are not licensed financial service provider by the authorized relevant financial service regulator in India or any other regulatory government body, and we do not offer or facilitate any trading, brokerage, investment, or financial advisory services. We do not deliberately target an audience seeking financial services.

By accessing this website, you acknowledge and confirm that you are seeking information relating to Musaffa of your own accord, and that there has been no form of solicitation, advertisement, or inducement by Musaffa or its members. Musaffa shall not be liable for the consequences of any action taken by relying on the material or information provided on this website. The contents of this website are the intellectual property of Musaffa.